Clinical study evaluates safety and efficacy of methylone in patients with severe PTSD

Clerkenwell Health, the modern mental health company specializing in matching patients with cutting-edge psychiatry treatments, today announced that it is taking part in Transcend Therapeutics’ Phase 2 study evaluating the safety and efficacy of methylone in patients with severe PTSD.

A Moral Code: Ethical Dilemmas in Medicine

Listen and subscribe to Anamnesis by searching for MedPod Today on Apple and Spotify so you don’t miss the next episode. Amy Ho: Hey everyone

October 26, 2024

Opinion | A Bright Future for Gender-Affirming Care

Emily Hutto is an Associate Video Producer & Editor for MedPage Today. She is based in Manhattan. In this Instagram Live clip, Jeremy Faust, MD,

July 28, 2023

FDA expands approval of Dupixent for eosinophilic esophagitis in children – Pharmaceutical Technology

Share this article Patients aged 1–11 years and weighing at least 15kg with the oesophageal allergic inflammation will now have access to the drug. Credit:

January 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.